Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease

被引：16
|
作者：
Marion, JF [1 ]
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
来源：
INFLAMMATORY BOWEL DISEASES | 1998年 / 4卷 / 02期
关键词：
adverse reactions; azathioprine; Crohn's disease; drug use in pregnancy; 6-mercaptopurine; pediatric; ulcerative colitis;
D O I：
10.1097/00054725-199805000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [31] Long term safety and efficacy of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
    Leung, Yvette
    Sparrow, Miles
    Hanauer, Stephen B.
    GASTROENTEROLOGY, 2008, 134 (04) : A209 - A210
  • [32] Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Gisbert, JP
    Luma, M
    Maté, J
    González-Guijarro, L
    Cara, C
    Pajares, JM
    MEDICINA CLINICA, 2003, 121 (01): : 1 - 5
  • [33] Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Kandiel, A
    Fraser, AG
    Korelitz, BI
    Brensinger, C
    Lewis, JD
    GUT, 2005, 54 (08) : 1121 - 1125
  • [34] Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
    Mottet, Christian
    Schoepfer, Alain M.
    Juillerat, Pascal
    Cosnes, Jacques
    Froehlich, Florian
    Kessler-Brondolo, Vera
    Seibold, Frank
    Rogler, Gerhard
    Vavricka, Stephan R.
    Michetti, Pierre
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (11) : 2733 - 2747
  • [35] Treatment regimens of azathioprine or 6-mercaptopurine in Inflammatory bowel disease in clinical practice
    van Marrewijk, C. J.
    Franke, B.
    Coenen, M. J. H.
    Derrijks, L. J. J.
    Guchelaar, H. J.
    Klungel, O. H.
    Marle, M. E. v. d. Akker-V.
    Verbeek, A. L. M.
    Vermeulen, H. M. M.
    Scheffer, H.
    de Jong, D. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A33 - A33
  • [36] Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
    Leung, Yvette
    Sparrow, Miles P.
    Schwartz, Marc
    Hanauer, Stephen B.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03): : 162 - 167
  • [37] The use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel diseases
    Gutkowski, Krzysztof
    Hartleb, Marek
    PRZEGLAD GASTROENTEROLOGICZNY, 2009, 4 (05): : 225 - 230
  • [38] Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
    Kader, HA
    Wenner, WJ
    Telega, GW
    Maller, ES
    Baldassano, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (04) : 409 - 413
  • [39] Severe pulmonary toxicity following azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease: a case series
    Ananthakrishran, AN
    Atilla, T
    Bajaj, JS
    Otterson, MF
    Lipchick, R
    Massey, BT
    Maloney, J
    Komorowski, R
    Binion, DG
    GASTROENTEROLOGY, 2005, 128 (04) : A575 - A575
  • [40] Allopurinol optimizes 6-thioguanine production in inflammatory bowel disease patients not responding to azathioprine or 6-mercaptopurine
    Sparrow, MP
    Hande, SA
    Friedman, S
    Reddy, S
    Lim, WC
    Hanauer, SB
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S287 - S288
12345